Known information
- Has over 15 years of experience across strategic and operational functions, including program and alliance management, portfolio planning, and R&D strategy and commercialization
- Was Senior Director, Portfolio Strategy and Operations for Relay Therapeutics, contributing to portfolio strategies for pipeline programs and responsible for alliance management with a large biopharma partnership and a research collaboration
- Served as Senior Director of Program Leadership at Deciphera Pharmaceuticals, where she was the program lead for two oncology drug programs including one through product approval
- Had a tenure at Biogen, culminating in the role of Director, R&D Strategy and Portfolio Leadership for several disease areas
- Earlier roles at Biogen included portfolio strategy for spinal muscular atrophy, launching SPINRAZA as part of the global brand team and new product commercialization for the immunology therapeutic area
- Holds a BS from Babson College, an MBA from the MIT Sloan School of Management, and a Master of Science (SM) from the Harvard-MIT Health Sciences and Technology Program
About Seismic Therapeutic
Seismic Therapeutic is a biotech company using machine learning to develop biologics for autoimmune diseases, with a focus on novel enzyme and antibody therapeutics.